Tue.Oct 15, 2024

article thumbnail

UnitedHealthcare rolls out new therapy restrictions for Medicare Advantage plans

STAT

You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine. Sign up  to get it in your inbox every Monday. Hello, you spry bunch. We’re coming to you on a Tuesday after yesterday’s holiday. What are you looking to read more about as the year winds down? Let us know: bob.herman@statnews.com.

article thumbnail

AlphaFold’s Nobel Prize is ‘the dawn of a new era’ in mapping drug development potential

PharmaVoice

A Nobel Prize in chemistry for Google’s DeepMind protein-structure mapping is the tip of the iceberg for advances in drug discovery and development.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

11 experts on why gains in cardiovascular disease are stalling and what we can do about it

STAT

It was a dramatic call to action by the American Heart Association: The organization declared its decade-long goal culminating in 2020 was to slash deaths from cardiovascular disease and stroke by 20%. It also promised in its scientific journal to move all Americans toward “ideal cardiovascular health.” That never happened. Deaths did decrease by 15% from 2010, but it was a “disappointment” that fatalities linked to conditions like high blood pressure, heart failure,

356
356
article thumbnail

Fulfilling My Purpose as a Future Bilingual Pharmacist – Honoring Hispanic Heritage in Pharmacy

Pharmacy Is Right For Me

Hello everyone, my name is Diana Martinez-Nava and I am a fourth-year student pharmacist at The University of New Mexico College of Pharmacy. I would like to take some time on this special month celebrating our Hispanic Heritage to share my story on my pharmacy journey. My interest in becoming a pharmacist began around the time I was 8 years old. I was that small child who could barely see over the counter at our neighborhood pharmacy next to my father’s arm who would be reaching out to collect,

Diabetes 130
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

STAT+: Yale tested 6 early-warning algorithms used by health systems. Epic’s AI tool didn’t fare well

STAT

In the early days of the Covid-19 pandemic, hospitals were desperate for ways to manage the flood of seriously ill patients. Many turned to an artificial intelligence algorithm developed by Epic Systems , the electronic health record company, to predict which patients were most likely to rapidly deteriorate so they could get the critical care they needed.

Hospitals 340
article thumbnail

Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch.

PharmaVoice

Data readouts over the next six months could set expectations for how the highly lucrative market for weight loss therapies will look in the future.

130
130

More Trending

article thumbnail

Lundbeck drops in on epilepsy drug with $2.6bn Longboard bid

pharmaphorum

Neuroscience specialist Lundbeck has agreed to buy Longboard Pharmaceuticals for $2.6 billion, expanding its pipeline with an epilepsy drug tipped as a future blockbuster.The Danish drugmaker has offered $60 per share for California biotech Longboard, with the main asset in the deal bexicaserin, an oral, centrally acting serotonin 5-HT 2C receptor super-agonist in late-stage testing for seizures associated with rare forms of epilepsy.

104
104
article thumbnail

STAT+: Pharmalittle: We’re reading about generic weight loss drugs, anxiety over a Sanofi deal, and more

STAT

Hello, everyone, and how are you today? We are doing just fine, thank you, especially after a lengthy weekend respite. Of course, we have returned to the usual routines, so we are firing up the trusty coffee kettle as we brace for another round of deadlines, online meetings, and the like. No doubt, you may relate. So please join us as we hoist our cup of stimulation — our choice today is cinnamon vanilla — and get cracking.

Diabetes 278
article thumbnail

Leaders cast their vision for the future of community pharmacy

The Pharmacist

Community pharmacy leaders shared their vision for the future of community pharmacy at the Pharmacy Show in Birmingham yesterday. Several leaders spoke about the need for adequate funding for the sector, the importance of upskilling, and the potential for pharmacies to do much more in terms of long-terms conditions management and prevention. Meeting local community […] The post Leaders cast their vision for the future of community pharmacy appeared first on The Pharmacist.

article thumbnail

Does AI make patient portal responses better? Depends on who you ask

STAT

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday. Why nurses liked an AI bot more than doctors did An interesting research letter out in JAMA Network Open suggests attitudes toward large language models in health care could vary based on license and professional role.

276
276
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

GSK turns its guns on Moderna in mRNA jab patent dispute

pharmaphorum

GSK has filed lawsuits against Moderna, claiming infringement of patents covering mRNA vaccines for COVID-19 and RSV

Vaccines 116
article thumbnail

Morning Rounds: Why aren’t we doing better on cardiovascular health?

STAT

It’s the most wonderful time of the year — STAT Summit week! I love when my colleagues come into town, and not only because it means we’re more likely to get free lunch at the office. (Today? I heard pizza!)  There are a lot of great conversations ahead. It’s not too late for you to join us , in person or virtually! Why aren’t we doing better in the battle against cardiovascular disease?

244
244
article thumbnail

If Plan Sponsors Are So Unhappy with Their PBMs’ Transparency, Why Won’t They Change the Model?

Drug Channels

A new survey of plan sponsors sheds light on their satisfaction with transparency at large and small pharmacy benefit managers (PBMs). As you will see, clients remain slightly more satisfied with the perceived transparency of smaller PBMs compared with the Big Three PBMs—CVS Caremark, Express Scripts, and Optum Rx. However, plan sponsors are dissatisfied with transparency about how both large and small PBMs make money.

89
article thumbnail

The biotech news you missed this weekend

STAT

Hello! Hope you had a restful and reflective Indigenous Peoples’ Day. Today, we talk about how the autoimmune disease space is hotter than ever, see more gene therapy contraction, and the CEO of a generics giant talks about how elections affect industry. The need-to-know this morning Johnson & Johnson reported third-quarter earnings. Investment in autoimmune disease is soaring Investment has surged this year in autoimmune disease: More than $1.7 billion has been committed to this spac

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Celltrion unveils promising dose escalation results for subcutaneous infliximab

Pharma Times

Study reveals potential new strategy for managing inflammatory bowel disease

124
124
article thumbnail

Heart disease experts in their own words: ‘This is solvable and this is preventable’

STAT

Why aren’t we doing better in the battle against cardiovascular disease?  Over the last few months, STAT put that question to nearly a dozen experts in cardiology, primary care, endocrinology, and vascular disease. Nearly all of them, as a related article details, pointed to a crisis in primary care.

295
295
article thumbnail

US digital health spending set to increase, survey finds

pharmaphorum

Health plans, employers, and healthcare providers plan to increase their spending on digital health technologies in the next 12 months, says PHTI survey

101
101
article thumbnail

Opinion: STAT+: What the Sandoz CEO is thinking about the 2024 elections

STAT

As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceutical companies to reflect on how their industry is being portrayed in the presidential campaign — and what their hopes are for a new presidential administration.  With all eyes currently on the upcoming U.S. elections, it’s easy to forget that this year more than 75 countries have headed to the polls or will soon.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

How warehouse automation is creating impact on medical distribution

Express Pharma

Efficient and safe delivery of medical supplies, equipment, and pharmaceuticals depends on effective healthcare supply chains. They provide timely, safe access to necessary healthcare-related resources. Warehouse automation may mark a sea change for the medical distribution industry, smoothing out traditional pain points and yielding a massive change in gains related to increased efficiency, precision, and fiscal responsibility.

article thumbnail

GITEX GLOBAL 2024: Huawei launches a series of industrial digital and intelligent transformation solutions, and flagship products

Pharmaceutical Technology

Huawei hosted GITEX's Industrial Digital and Intelligent Transformation Summit and launched joint solutions with partners for ten industries.

93
article thumbnail

CMO Symbiosis acquires 20,000 sq/ft facility, £1.2m financed by Barclays Corporate Bank

Express Pharma

Symbiosis Pharmaceutical Services, a Contract Manufacturing Organisation ( CMO) and biopharmaceutical development services provider announces the purchase of new premises in Stirling, Scotland, UK. The additional space will double the total footprint of the company across the four facilities that it will operate from, increasing manufacturing capacity by 50 per cent in the short term.

article thumbnail

Creepy, Stalking Bosses

The Honest Apothecary

Social media has managed to blur the lines between work life and home life. These days many of us are growing more comfortable openly sharing things about ourselves that might not normally be public knowledge to our co-workers or our boss. With just a few clicks our pals at work can be flipping through our […] The post Creepy, Stalking Bosses appeared first on The Honest Apothecary.

80
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

A new photocatalyst can efficiently degrade broad-spectrum antibiotics

Express Pharma

Scientists have developed an efficient photocatalyst that can degrade sulfamethoxazole, a broad-spectrum antibiotic to less hazardous chemicals and reduce health and environmental concerns associated with antibiotic contamination. A team of scientists from the Institute of Advanced Study in Science and Technology (IASST), Guwahati, an autonomous institute of the Department of Science and Technology have synthesised copper zinc tin sulfide Cu2ZnSnS4 (CZTS) nanoparticles (NPs) and copper zinc tin

101
101
article thumbnail

Beyond COVID-19: mRNA vaccines aim to revolutionise cancer care

pharmaphorum

mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment.

article thumbnail

Government enters ‘strategic collaboration’ with tirzepatide obesity drug maker

The Pharmacist

The UK government, devolved nations and NHS England have signed a collaboration agreement with Lilly, the pharmaceutical giant behind weight loss medication tirzepatide. The government said the ‘strategic’ agreement will see Lilly investing a further £279m in the UK life sciences industry, in a bid to find new treatment models for major illnesses including obesity. […] The post Government enters ‘strategic collaboration’ with tirzepatide obesity drug maker appeared first on The Pharmacist.

81
article thumbnail

Transgene cervical cancer shot misses the mark in phase 2

pharmaphorum

Transgene's therapeutic vaccine for cervical and anogenital cancers failed a phase 2 trial, but an efficacy signal warrants further study

article thumbnail

The 92-Day Pill Puzzle: Why Your 3-Month Supply Doesn’t Add Up

Drug Patent Watch

Have you ever found yourself scratching your head at the pharmacy counter, wondering why your “3-month supply” of medication doesn’t quite match up with the calendar? You’re not alone. Many people are puzzled by the discrepancy between a 92-day supply of pills and the actual number of days in a three-month period.

71
article thumbnail

Taiwo Owatemi: 'MPs aren't hearing enough about pharmacy'

The Pharmacist

Pharmacists must raise concerns with their local MPs about the issues they are facing, the Labour MP for Coventry North West and government whip Taiwo Owatemi has urged. Ms Owatemi, who is herself a pharmacist, said the profession needed to speak with a unified voice, be more vocal about concerns and collaborate with other professions. […] The post Taiwo Owatemi: 'MPs aren't hearing enough about pharmacy' appeared first on The Pharmacist.

70
article thumbnail

LEO launches chronic hand eczema drug in its first market

pharmaphorum

Germany is the first market for LEO Pharma's Anzupgo, the first topical treatment specifically approved for chronic hand eczema

92
article thumbnail

Sanofi abandons phase 2 trial of Denali’s multiple sclerosis candidate

Outsourcing Pharma

The big pharma company Sanofi has discontinued a phase 2 trial of U.S. partner Denali Therapeuticsâ oditrasertib for the treatment of multiple sclerosis after the drug failed to perform.

64
article thumbnail

‘The UK is at the back of the race of turtles’: Sanofi’s boss on the need to develop new medicines

The Guardian - Pharmaceutical Industry

Paul Hudson, the Briton in charge of the French drug firm, is a big believer in the potential of AI to transform healthcare Paul Hudson, the Briton who leads the French drug firm Sanofi, is “immensely” proud to have carried the torch at the recent Paralympics opening ceremony along with fellow employees, as the firm was one of the sponsors of both sets of Paris games.

article thumbnail

Lupin launches first generic of Pred Forte in the US

Express Pharma

Lupin announced the launch of the first generic version of Pred Forte (Prednisolone Acetate) Ophthalmic Suspension USP, 1 per cent in the United States. Being the first generic to be approved and launched, the company is entitled to 180-day competitive generic therapy (CGT) exclusivity. Prednisolone Acetate Ophthalmic Suspension USP, 1 per cent is a generic equivalent of Pred Forte Ophthalmic Suspension, 1 per cent of AbbVie, and is indicated for the treatment of steroid-responsive inflammation

76